Keith Mitchell Skubitz MD
Hematologic Oncology
Professor, Lab Medicine & Pathology, University of Minnesota Medical School
Join to View Full Profile
424 Harvard Street SeMasonic Cancer Center, First Floor, Suite M100Minneapolis, MN 55455
Phone+1 612-676-4200
Fax+1 612-626-1441
Dr. Skubitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 1982 - 1983
Johns Hopkins University School of MedicineFellowship, Clinical Pharmacology, 1979 - 1981- University of MinnesotaResidency, Internal Medicine, 1976 - 1979
- Johns Hopkins University School of MedicineClass of 1976
Certifications & Licensure
MN State Medical License 1978 - 2026
MD State Medical License 1980 - 1983
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma Start of enrollment: 2014 Jun 13
Publications & Presentations
PubMed
- Evolution of CEACAM1 N Domain Biologically Active Sites in Primates.Keith M Skubitz, Wolfgang Zimmermann
Biology. 2025-12-05 - 5-fluoro-deoxyglucose PET/CT response after neoadjuvant chemotherapy predicts long-term outcomes in soft tissue sarcomas: Results from a prospective trial.Edward Y Cheng, Andrea P Espejo Freire, Juan C Manivel, Jerry W Froelich, Brenda J Weigel
Cancer. 2025-10-15 - 2 citationsClinical Benefit of Pegylated Liposomal Doxorubicin and High Prevalence of Pre-Existing Psychiatric Conditions in Patients with Desmoid-Type Fibromatosis.Andrea Espejo Freire, Keith M Skubitz
Cancers. 2025-01-17
Grant Support
- IL 2 Liposomes In Lung CancerNational Center For Research Resources1997–2000
- A Pilot Study Of Continuous Infusion Taxol For Refractory MalignanciesNational Center For Research Resources1996–1997
- Granulocyte Membrane Structure And FunctionNational Cancer Institute1985–1989
- Granulocyte Membrane Structure &FunctionNational Cancer Institute1987–1988
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
